Polymyositis and dermatomyositis associated with malignancy: a 30-year retrospective study
- PMID: 12452993
- DOI: 10.1046/j.1365-4362.2002.01648.x
Polymyositis and dermatomyositis associated with malignancy: a 30-year retrospective study
Abstract
Background: Polymyositis and dermatomyositis in association with malignancy are paraneoplastic syndromes, but the incidence, treatment and factors that predict associated cancer and its prognosis all remain unclear.
Patients and method: During the 30-year period 1969-99, we treated 64 patients who had polymyositis (including two with cancer) and 28 patients who had dermatomyositis (including 10 with cancer). We compared the clinical findings of the patients who had cancer with the findings of those who did not have cancer.
Results: The risk of cancer is significantly higher in dermatomyositis and somewhat higher in polymyositis. An increased cancer risk was found in male patients with dermatomyositis who were older than 50 years. Cancer was diagnosed within 4 years before or after the diagnosis of polymyositis or dermatomyositis, and usually within 1 year. An operation was not possible in many of the patients with cancer because of the advanced stage of the disease.
Conclusion: Our findings suggest that early discovery of malignancy is critical in cases of polymyositis and dermatomyositis.
Similar articles
-
Clinical characteristics and prognosis of polymyositis and dermatomyositis associated with malignancy: a 25-year retrospective study.Rheumatol Int. 2019 Oct;39(10):1733-1739. doi: 10.1007/s00296-019-04428-z. Epub 2019 Aug 23. Rheumatol Int. 2019. PMID: 31444556
-
Long-term follow-up of 76 Iranian patients with idiopathic inflammatory myopathies.Int J Rheum Dis. 2018 Aug;21(8):1627-1633. doi: 10.1111/1756-185X.13352. Int J Rheum Dis. 2018. PMID: 30146744
-
[Myositis associated with malignancy].Ryoikibetsu Shokogun Shirizu. 2001;(35):291-5. Ryoikibetsu Shokogun Shirizu. 2001. PMID: 11555933 Review. Japanese. No abstract available.
-
Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study.Br J Cancer. 2001 Jul 6;85(1):41-5. doi: 10.1054/bjoc.2001.1699. Br J Cancer. 2001. PMID: 11437400 Free PMC article.
-
Risk of Malignancy in Dermatomyositis and Polymyositis.J Cutan Med Surg. 2017 Mar/Apr;21(2):131-136. doi: 10.1177/1203475416665601. Epub 2016 Aug 20. J Cutan Med Surg. 2017. PMID: 27534779 Review.
Cited by
-
[Dermatomyositis in the elderly: a study of 4 cases in southern Tunisia].Pan Afr Med J. 2012;13:26. Epub 2012 Oct 6. Pan Afr Med J. 2012. PMID: 23308331 Free PMC article. French.
-
Idiopathic Inflammatory Myopathies and Malignancy: a Comprehensive Review.Clin Rev Allergy Immunol. 2017 Feb;52(1):20-33. doi: 10.1007/s12016-015-8511-x. Clin Rev Allergy Immunol. 2017. PMID: 26429706 Review.
-
Genetic Influences in Cancer-Associated Myositis.Arthritis Rheumatol. 2023 Feb;75(2):153-163. doi: 10.1002/art.42345. Epub 2022 Dec 20. Arthritis Rheumatol. 2023. PMID: 36053262 Free PMC article. Review.
-
Pharyngeal-Esophageal Malignancies with Dermatologic Paraneoplastic Syndrome.Life (Basel). 2022 Oct 26;12(11):1705. doi: 10.3390/life12111705. Life (Basel). 2022. PMID: 36362860 Free PMC article.
-
Malignancy in dermatomyositis and polymyositis: analysis of 192 patients.Clin Rheumatol. 2016 Aug;35(8):1977-1984. doi: 10.1007/s10067-016-3296-8. Epub 2016 May 23. Clin Rheumatol. 2016. PMID: 27210465
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources